“…Fecal and circulating levels of calprotectin have been used as a biomarker to track the gut inflammatory activity in human [ 78 , 79 , 80 , 81 , 82 , 83 ] and canine [ 74 , 84 , 85 , 86 ] patients with chronic enteropathies. In swine, the biomarker has been applied to evaluate the intestinal disruption by pathogenic enterobacteria and their toxins [ 87 , 88 , 89 , 90 , 91 , 92 ], but also to evaluate the positive effects of dietary supplementations on the intestinal inflammation and integrity [ 92 , 93 , 94 ]. Studies in human health show that the blood levels of calprotectin increase in response to diverse conditions involving tissue damage and inflammation, not exclusively in the intestine [ 72 , 95 ].…”